Taysha Gene Therapies (TSHA) EPS (Basic) (2020 - 2026)
Taysha Gene Therapies (TSHA) reported EPS (Basic) of -$0.12 for Q1 2026, down 44.7% on a YoY basis from -$0.21 in Q1 2025, and down 32.79% sequentially from -$0.09 in Q4 2025.
Taysha Gene Therapies (TSHA) EPS (Basic) (2020 - 2026) Analysis & Trends
Taysha Gene Therapies (TSHA) has 7 years of EPS (Basic) data on file, last reported at -$0.12 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 44.7% year-over-year to -$0.12; the trailing twelve-month figure through Mar 2026 stood at -$0.35 (down 9.95% YoY), and the FY2025 full-year result was -$0.34, up 4.51% from the prior year.
- EPS (Basic) slipped to -$0.12 in Q1 2026, from -$0.09 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.41 in Q4 2023 to a low of -$1.32 in Q1 2022.
- A 5-year average of -$0.36 and a median of -$0.1 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 132.81% in 2023 and sank 118.27% in 2024, its largest moves.
- Tracing TSHA's EPS (Basic) over 5 years: stood at -$1.25 in 2022, then surged by 132.81% to $0.41 in 2023, then plunged by 118.27% to -$0.08 in 2024, then decreased by 16.0% to -$0.09 in 2025, then tumbled by 32.79% to -$0.12 in 2026.
- Business Quant data shows TSHA's EPS (Basic) at -$0.12 in Q1 2026, -$0.09 in Q4 2025, and -$0.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Taysha Gene Therapies | 2.01 Bn | 2.01 Bn | - | -0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.12 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.08 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | 0.41 |
| Sep 30, 2023 | -0.93 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -0.28 |
| Dec 31, 2022 | -1.25 |
| Sep 30, 2022 | -0.65 |
| Jun 30, 2022 | -0.85 |
| Mar 31, 2022 | -1.32 |
| Dec 31, 2021 | -1.34 |
| Sep 30, 2021 | -1.35 |
| Jun 30, 2021 | -1.09 |